Rheumatology in Livingston, NJ
3 verified rheumatology doctors in Livingston.
Rheumatologists treat autoimmune and inflammatory conditions affecting the joints, muscles, and connective tissue.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New Jersey State Board of Medical Examiners
Dr. Yelena Chuzhin, MD
Rheumatology
CMS Open Payments· $905.99 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$905.99
Total received
36
Transactions
8
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total ranks around the 71th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Yelena Chuzhin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jill Ritter, MD
Rheumatology
CMS Open Payments· $40.05 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$40.05
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Jill Ritter do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lee Kaufman, MD
Rheumatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.